Medium materiality6/10
Chemours price target lowered to $17 from $19 at Goldman Sachs
Why it may matterVerify against the original reporting
Upside potential remains with target above price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman cuts Chemours target to $17; current price around $15.24; price barely moved since signal.
- Target $17; price $15.24; +0.13%.
Key facts
- 01
Target: $17
- 02
Posted price: $15.24
- 03
Analyst firm: Goldman Sachs
- 04
Analyst: Duffy Fischer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.